ABOUT THE EVENT
The International Society for Cell & Gene Therapy (ISCT) North America Regional Signature Series on Artificial Intelligence will convene leading experts for a one-day thought leadership event exploring the transformative role of AI across the cell and gene therapy (CGT) sector.
As AI continues to reshape advanced therapies, the program will examine the opportunities associated with integrating AI into CGT manufacturing, quality systems, analytics, clinical applications, and collaborative data ecosystems. Through keynote presentations, fireside discussions, and expert-led panels, attendees will gain insight into the current state of AI adoption, emerging technologies, regulatory considerations, and future directions for the field.
Developed in collaboration with the MIT Center for Biomedical Innovation, the program is designed to bridge innovation with practical implementation, highlighting how AI is advancing manufacturing optimization, quality and analytical systems, clinical applications, and data-driven collaboration across the advanced therapy ecosystem.